Vitalhub Corp. (TSE:VHI) Receives C$13.14 Average PT from Analysts

Vitalhub Corp. (TSE:VHI) has received a consensus recommendation of “Buy” from the seven brokerages that are currently covering the firm, Marketbeat.com reports. Six investment analysts have rated the stock with a buy recommendation and one has issued a strong buy recommendation on the company. The average 12 month target price among brokerages that have updated their coverage on the stock in the last year is C$13.14.

Separately, National Bank Financial cut their price target on Vitalhub from C$14.00 to C$11.00 and set an “outperform” rating on the stock in a research note on Wednesday, May 27th.

Vitalhub Price Performance

VHI opened at C$6.67 on Monday. The stock has a market capitalization of C$421.94 million, a P/E ratio of 55.58, a price-to-earnings-growth ratio of 1.18 and a beta of 0.91. The company’s 50 day simple moving average is C$7.19 and its 200-day simple moving average is C$7.74. Vitalhub has a one year low of C$6.62 and a one year high of C$14.64.

Vitalhub (TSE:VHI) last posted its quarterly earnings data on Thursday, May 7th. The company reported C$0.04 earnings per share for the quarter. Vitalhub had a net margin of 6.13% and a return on equity of 2.98%. The firm had revenue of C$31.91 million during the quarter. As a group, analysts anticipate that Vitalhub will post 0.2296467 EPS for the current year.

Vitalhub Company Profile

VitalHub is a leading software company dedicated to empowering health and human services providers globally. VitalHub’s comprehensive product suite includes electronic health records, operational intelligence, and workforce automation solutions that serve over 1,300 clients across the UK, Canada, and other geographies. The Company has a robust two-pronged growth strategy, targeting organic opportunities within its product suite and pursuing an aggressive M&A plan. VitalHub is headquartered in Toronto with over 700 employees globally, across key regions and the VitalHub Innovations Lab in Sri Lanka.